The loss of N-IgG seropositivity in over half of the population after seven months, regardless of vaccination or reinfection status, and the absence of measurable N-IgM levels across the board suggests that the use of these markers to predict past infection may dramatically underestimate exposure rates. This evidence concerns the gene CD40LG and infection.